Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
A new lawsuit accuses Pfizer Inc. of failing to warn patients and doctors that its rheumatoid arthritis drug Xeljanz can cause sepsis in older patients, leading to necrosis and amputation.
A federal appeals court has upheld dismissal of a case accusing Merck & Co. of intentionally adding HPV DNA to its Gardasil HPV vaccine, ruling that the plaintiff failed to exhaust her administrative remedies as required by the Vaccine Act.
A woman who suffered complications after being implanted with an Ethicon Prolift transvaginal mesh device has established a link between the company’s allegedly inadequate warnings and her injuries, a Wisconsin federal judge has ruled.
Plaintiffs in the DePuy Pinnacle hip multidistrict litigation have asked a Texas federal judge to schedule a case management conference “to address outstanding issues concerning the status and management of unresolved cases in the MDL.”
A Pennsylvania federal judge has dismissed a Zostavax action, ruling that it is barred by the doctrine of res judicata because the court already awarded Merck summary judgment on the claims in a previous action on the basis of untimeliness.
A California man has sued Johnson & Johnson and its subsidiary Ethicon, accusing them of failing to warn patients and doctors that their recalled curved intraluminal surgical staplers were defectively manufactured and could cause serious injury and death.
Trial has begun in a lawsuit in which the California attorney general is accusing Johnson & Johnson and its subsidiary Ethicon of deceptively marketing its surgical mesh devices as safe while concealing a host of serious risks and complications, including permanent disability.
Issue #140, July 2019
A Louisiana federal judge has allowed two Taxotere permanent hair loss actions to proceed, ruling that the plaintiffs’ claims are timely and there are questions of fact as to whether the learned intermediary doctrine bars the negligence and failure-to-warn claims.
An Illinois federal judge has refused to reinstate a $3 million verdict in a Paxil suicide case despite a recent U.S. Supreme Court ruling in which it clarified the “clear evidence” standard in the context of whether the FDA would approve changes to a drug’s warning label.
An Ohio federal judge has remanded a Medtronic pacemaker case to state court for lack of federal question jurisdiction, finding there is no substantial federal issue because the state court will not have to decide whether any government action was proper or constitutional.